FHD-286

• Description:

  FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  562.66

• Molecular Formula:

  C24H30N6O6S2

• Notes:

  Research use only, not for human use.

• Receptor:

  ——

• CAS Number:

  2671128-05-3